CAP Opens PD-L1 Lung Tumor Testing Guideline for Public Comment

The College of American Pathologists (CAP), in collaboration with five other societies, developed a draft evidence-based clinical practice guideline that aims to optimize PD-L1 testing for patients with non-small cell lung cancer (NSCLC) who are being considered for immunooncology therapy.

CAP Opens Comment Period for MMR/MSI Testing, Advancing Care for Patients with Cancer

Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP) and three collaborating societies are developing a clinical guideline for testing DNA mismatch repair (MMR) and microsatellite instability (MSI) status in patients with a range of cancer types.

Elizabeth K. Usher named Executive Director/Chief Executive Officer of AAD/A

Elizabeth K. Usher, MBA, has been named executive director/chief executive officer of the American Academy of Dermatology and American Academy of Dermatology Association (AAD/A). Usher comes to the Academy from the College of American Pathologists (CAP), most recently holding the position of chief market and customer officer.

The Best in Pathology, Laboratory Quality, Proficiency Testing, Technology & Patient Safety

The College of American Pathologists Releases List of Longest Accredited Laboratories in U.S. Northfield, IL (June 24, 2019) This week, the College of American Pathologists (CAP) released a list of its longest accredited laboratories in the United States. These 41…